SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-21-007766
Filing Date
2021-11-10
Accepted
2021-11-10 07:01:19
Documents
79
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acst20210930_10q.htm   iXBRL 10-Q 1746376
2 EXHIBIT 31.1 ex_303778.htm EX-31.1 8900
3 EXHIBIT 31.2 ex_303779.htm EX-31.2 8865
4 EXHIBIT 32.1 ex_303780.htm EX-32.1 6629
5 EXHIBIT 32.2 ex_303781.htm EX-32.2 7098
11 image1.jpg GRAPHIC 80590
12 image2.jpg GRAPHIC 66906
13 image3.jpg GRAPHIC 76930
14 image4.jpg GRAPHIC 37213
15 image5.jpg GRAPHIC 54481
16 image6.jpg GRAPHIC 18352
17 image7.jpg GRAPHIC 25172
18 image8.jpg GRAPHIC 15451
19 image9.jpg GRAPHIC 60208
20 image10.jpg GRAPHIC 66854
21 image11.jpg GRAPHIC 50563
22 image12.jpg GRAPHIC 59770
  Complete submission text file 0001171843-21-007766.txt   7091341

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acst-20210930.xsd EX-101.SCH 49253
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acst-20210930_cal.xml EX-101.CAL 34095
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acst-20210930_def.xml EX-101.DEF 300422
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acst-20210930_lab.xml EX-101.LAB 243178
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acst-20210930_pre.xml EX-101.PRE 325491
23 EXTRACTED XBRL INSTANCE DOCUMENT acst20210930_10q_htm.xml XML 701422
Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-35776 | Film No.: 211394345
SIC: 2834 Pharmaceutical Preparations